Matches in Wikidata for { <http://www.wikidata.org/entity/Q72149448> ?p ?o ?g. }
- Q72149448 description "article scientifique publié en 1994" @default.
- Q72149448 description "artikull shkencor i botuar më 01 janar 1994" @default.
- Q72149448 description "artículu científicu espublizáu en xineru de 1994" @default.
- Q72149448 description "im Januar 1994 veröffentlichter wissenschaftlicher Artikel" @default.
- Q72149448 description "scientific article published on 01 January 1994" @default.
- Q72149448 description "wetenschappelijk artikel" @default.
- Q72149448 description "наукова стаття, опублікована в січні 1994" @default.
- Q72149448 name "The cardioprotector ADR-529 and high-dose epirubicin given in combination with cyclophosphamide, 5-fluorouracil, and tamoxifen: a phase I study in metastatic breast cancer" @default.
- Q72149448 name "The cardioprotector ADR-529 and high-dose epirubicin given in combination with cyclophosphamide, 5-fluorouracil, and tamoxifen: a phase I study in metastatic breast cancer" @default.
- Q72149448 name "The cardioprotector ADR-529 and high-dose epirubicin given in combination with cyclophosphamide, 5-fluorouracil, and tamoxifen: a phase I study in metastatic breast cancer" @default.
- Q72149448 type Item @default.
- Q72149448 label "The cardioprotector ADR-529 and high-dose epirubicin given in combination with cyclophosphamide, 5-fluorouracil, and tamoxifen: a phase I study in metastatic breast cancer" @default.
- Q72149448 label "The cardioprotector ADR-529 and high-dose epirubicin given in combination with cyclophosphamide, 5-fluorouracil, and tamoxifen: a phase I study in metastatic breast cancer" @default.
- Q72149448 label "The cardioprotector ADR-529 and high-dose epirubicin given in combination with cyclophosphamide, 5-fluorouracil, and tamoxifen: a phase I study in metastatic breast cancer" @default.
- Q72149448 prefLabel "The cardioprotector ADR-529 and high-dose epirubicin given in combination with cyclophosphamide, 5-fluorouracil, and tamoxifen: a phase I study in metastatic breast cancer" @default.
- Q72149448 prefLabel "The cardioprotector ADR-529 and high-dose epirubicin given in combination with cyclophosphamide, 5-fluorouracil, and tamoxifen: a phase I study in metastatic breast cancer" @default.
- Q72149448 prefLabel "The cardioprotector ADR-529 and high-dose epirubicin given in combination with cyclophosphamide, 5-fluorouracil, and tamoxifen: a phase I study in metastatic breast cancer" @default.
- Q72149448 P1433 Q72149448-C0D57D05-75B8-4999-8C9F-C8A510367DE1 @default.
- Q72149448 P1476 Q72149448-9C336C2A-A3C6-4421-B1B2-7BC660A3CAAA @default.
- Q72149448 P2093 Q72149448-0A546081-2FE6-4A7F-AC55-8FF31630785E @default.
- Q72149448 P2093 Q72149448-0A92150B-697D-4D41-97B1-6E9E0F52A8EA @default.
- Q72149448 P2093 Q72149448-6DB11047-A8E1-4408-B2C0-5CD9C996DF18 @default.
- Q72149448 P2093 Q72149448-BC033CFE-E370-4E67-A2A0-150A1122D491 @default.
- Q72149448 P2093 Q72149448-C383FCD3-40AD-4E9E-86F8-6E94509E5BA1 @default.
- Q72149448 P2093 Q72149448-C892F665-71D3-4CF2-B6A9-0051FE45F72C @default.
- Q72149448 P2860 Q72149448-1D3EA0C4-02E1-4382-9521-11E205E48B47 @default.
- Q72149448 P2860 Q72149448-2504F04D-FA3D-401A-80EF-7FF0C13C66E6 @default.
- Q72149448 P2860 Q72149448-25CCF46A-8CB0-4375-AA9E-AEC0836CDD35 @default.
- Q72149448 P2860 Q72149448-2A1F1731-4E53-4546-84AC-6B0E0A29DA5C @default.
- Q72149448 P2860 Q72149448-32E15F3C-DE4B-4917-8941-5D34DAB70A6D @default.
- Q72149448 P2860 Q72149448-38E56513-0D5E-40DB-A46E-6396C9058123 @default.
- Q72149448 P2860 Q72149448-3F935EED-FCAC-4B8E-BE5E-8EFE2C29DC6F @default.
- Q72149448 P2860 Q72149448-53ACE87C-1AF6-423A-928A-31513BFBF371 @default.
- Q72149448 P2860 Q72149448-55D87F7C-D7A8-44CA-94D7-3F76E02FA805 @default.
- Q72149448 P2860 Q72149448-59BEEAB7-1006-43AB-B855-D7685661F183 @default.
- Q72149448 P2860 Q72149448-633DDB59-D8EB-4F26-B837-70C00E74B2EE @default.
- Q72149448 P2860 Q72149448-6705B7CE-1952-4DC2-A27F-7E657778BB02 @default.
- Q72149448 P2860 Q72149448-71FAF15B-C9F7-4894-9251-F02B00DF6ADF @default.
- Q72149448 P2860 Q72149448-85468AA1-CAB6-4C75-BCEC-40875F170809 @default.
- Q72149448 P2860 Q72149448-91C4A244-529B-44B0-918C-9BF2C265AD13 @default.
- Q72149448 P2860 Q72149448-BDB454B9-FD47-4733-ABC5-3D6EF6A5309A @default.
- Q72149448 P2860 Q72149448-C60FF30A-0137-4D35-8C11-B311CBD4CB78 @default.
- Q72149448 P2860 Q72149448-CDEF0453-203F-4C24-AAC1-55F029B87496 @default.
- Q72149448 P2860 Q72149448-D880A6CE-7EA3-435B-95B5-0FC85590EC36 @default.
- Q72149448 P2860 Q72149448-E2D64DC8-2AD1-4114-B7EA-7DB91A0A1219 @default.
- Q72149448 P2860 Q72149448-E736C6E4-FABF-49B8-BD59-BA2896BA2370 @default.
- Q72149448 P2860 Q72149448-E8C999CD-545B-4EF1-B8D3-BCE126C0D510 @default.
- Q72149448 P2860 Q72149448-EDEBA1FE-DFDC-47BC-8757-588E5F052CD2 @default.
- Q72149448 P2888 Q72149448-49C4A9B7-0F1C-4561-AED7-A752011298A9 @default.
- Q72149448 P304 Q72149448-18CCAD35-8652-423C-8CD1-77BC66DAA2D4 @default.
- Q72149448 P31 Q72149448-65E3D40F-C01C-4829-92CF-4E78CE008AAE @default.
- Q72149448 P356 Q72149448-0C7AC9DA-3B1F-4427-AE91-D32A40BA9BEA @default.
- Q72149448 P433 Q72149448-F2A93691-8B3B-4591-8B5B-AA9F05907834 @default.
- Q72149448 P478 Q72149448-18DBE20A-1E72-4753-9857-4091949310E0 @default.
- Q72149448 P50 Q72149448-3C53DFF6-FEA0-44D2-ACE9-ED111CFA92D6 @default.
- Q72149448 P577 Q72149448-7B6EC6E4-D64D-4E1E-A552-F627A907262C @default.
- Q72149448 P698 Q72149448-B6578FF5-90CD-4C47-940F-D43D95046D95 @default.
- Q72149448 P921 Q72149448-0533FFC6-3854-40C8-8370-F53833868F7B @default.
- Q72149448 P921 Q72149448-360ACF5E-EDF9-4FCB-9928-A667A30D8B86 @default.
- Q72149448 P921 Q72149448-FC139217-EECF-4021-AEEF-CEA41404629F @default.
- Q72149448 P356 BF00685571 @default.
- Q72149448 P698 8070013 @default.
- Q72149448 P1433 Q326137 @default.
- Q72149448 P1476 "The cardioprotector ADR-529 and high-dose epirubicin given in combination with cyclophosphamide, 5-fluorouracil, and tamoxifen: a phase I study in metastatic breast cancer" @default.
- Q72149448 P2093 "B Sørensen" @default.
- Q72149448 P2093 "C Rose" @default.
- Q72149448 P2093 "H T Mouridsen" @default.
- Q72149448 P2093 "M R Mirza" @default.
- Q72149448 P2093 "P Jakobsen" @default.
- Q72149448 P2093 "S B Gjedde" @default.
- Q72149448 P2860 Q28317288 @default.
- Q72149448 P2860 Q28320156 @default.
- Q72149448 P2860 Q28324350 @default.
- Q72149448 P2860 Q28367382 @default.
- Q72149448 P2860 Q38036275 @default.
- Q72149448 P2860 Q40783194 @default.
- Q72149448 P2860 Q42208685 @default.
- Q72149448 P2860 Q56680781 @default.
- Q72149448 P2860 Q67020006 @default.
- Q72149448 P2860 Q67581954 @default.
- Q72149448 P2860 Q67717245 @default.
- Q72149448 P2860 Q68254086 @default.
- Q72149448 P2860 Q68920496 @default.
- Q72149448 P2860 Q69189901 @default.
- Q72149448 P2860 Q69350870 @default.
- Q72149448 P2860 Q69936656 @default.
- Q72149448 P2860 Q70095473 @default.
- Q72149448 P2860 Q70292571 @default.
- Q72149448 P2860 Q70438286 @default.
- Q72149448 P2860 Q70468879 @default.
- Q72149448 P2860 Q70565399 @default.
- Q72149448 P2860 Q71545734 @default.
- Q72149448 P2860 Q71562320 @default.
- Q72149448 P2888 bf00685571 @default.
- Q72149448 P304 "439-443" @default.
- Q72149448 P31 Q13442814 @default.
- Q72149448 P356 "10.1007/BF00685571" @default.
- Q72149448 P433 "5" @default.
- Q72149448 P478 "34" @default.
- Q72149448 P50 Q56849196 @default.